Furafylline

CAS No. 80288-49-9

Furafylline ( —— )

Catalog No. M20761 CAS No. 80288-49-9

Furafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 267 In Stock
10MG 417 In Stock
25MG 689 In Stock
50MG 963 In Stock
100MG 1305 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Furafylline
  • Note
    Research use only not for human use.
  • Brief Description
    Furafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
  • Description
    Furafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    80288-49-9
  • Formula Weight
    260.25
  • Molecular Formula
    C12H12N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:12.5 mg/mL (48.03 mM)
  • SMILES
    Cc1nc2n(Cc3ccco3)c(=O)n(C)c(=O)c2[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sesardic D Boobis A R Murray B P et al. Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.[J]. British Journal of Clinical Pharmacology 1990 29(6):651-663.
molnova catalog
related products
  • Ginsenoside F1

    Ginsenoside F1,an enzymatically modified derivative of ginsenoside Rg1, protection from ultraviolet-B-induced apoptosis is tightly correlated with ginsenoside-F1-mediated inhibition of ultraviolet-B-induced downregulation of Bcl-2 and Brn-3a expression.

  • (R)-Etomoxir sodium ...

    (R)-Etomoxir sodium salt is R-form of Etomoxir. Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).

  • Ellagic Acid Dihydra...

    Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.